D. Poster

发表

Sirolimus and kidney growth in autosomal dominant polycystic kidney disease.

Oliver Senn, Dominik Weishaupt, D. Weishaupt, 2010, The New England journal of medicine.

Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months.

Oliver Senn, Dominik Weishaupt, D. Weishaupt, 2009, Kidney international.

Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphate.

R. Wüthrich, A. Serra, D. Poster, 2011, Kidney international.

Kidney function and volume progression in unilateral autosomal dominant polycystic kidney disease with contralateral renal agenesis or hypoplasia: a case series.

D. Weishaupt, H. Rennert, R. Wüthrich, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Soluble klotho and autosomal dominant polycystic kidney disease.

R. Wüthrich, A. Serra, D. Poster, 2012, Clinical journal of the American Society of Nephrology : CJASN.

Ovarian toxicity from sirolimus.

R. Wüthrich, A. Serra, D. Poster, 2012, The New England journal of medicine.

Low-Dose Oral Sirolimus and the Risk of Menstrual-Cycle Disturbances and Ovarian Cysts: Analysis of the Randomized Controlled SUISSE ADPKD Trial

A. von Eckardstein, R. Wüthrich, A. Serra, 2012, PloS one.

Urinary Biomarkers at Early ADPKD Disease Stage

A. Serra, D. Poster, F. Krauer, 2015, PloS one.

Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study

D. Weishaupt, R. Wüthrich, A. Serra, 2007, BMC nephrology.

Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease.

H. Mischak, M. Dakna, R. Wüthrich, 2009, Kidney international.

Urinary Proteomic Biomarkers for Diagnosis and Risk Stratification of Autosomal Dominant Polycystic Kidney Disease: A Multicentric Study

K. Bae, H. Mischak, A. Chapman, 2013, PloS one.

Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.

R. Wüthrich, A. Serra, D. Poster, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Correction: Urinary Proteomic Biomarkers for Diagnosis and Risk Stratification of Autosomal Dominant Polycystic Kidney Disease: A Multicentric Study

K. Bae, H. Mischak, A. Chapman, 2013, PLoS ONE.

Safety and tolerability of sirolimus treatment in patients with autosomal dominant polycystic kidney disease.

D. Weishaupt, A. Regeniter, R. Wüthrich, 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Growth of arachnoid cysts in patients with autosomal dominant polycystic kidney disease: serial imaging and clinical relevance

S. Kollias, R. Wüthrich, A. Serra, 2012, Clinical kidney journal.